Strong Industry Position GATC Biotech is Europe’s leading DNA sequencing service provider with over two decades of experience, making it a trusted partner for both industry and academic research institutions seeking advanced genome analysis solutions.

Recent Collaborations Strategic partnerships, such as the collaboration with Fraunhofer ILT and other research institutes, demonstrate GATC's active engagement in innovative projects, presenting opportunities to offer complementary bioinformatics and sequencing technologies.

Acquisition Advantage Being acquired by Eurofins in 2017 has enhanced GATC’s capabilities and market reach, providing a platform for selling integrated testing services and expanding into new diagnostic markets.

Product Innovation GATC’s launch of new service families like GATCLIQUID and advanced transcript isoform characterization indicates ongoing product development, opening sales avenues for cutting-edge genomics and diagnostic solutions.

Market Potential With a revenue range of $100M to $1B and serving a broad client base spanning biotechnology and research sectors, GATC presents numerous cross-selling opportunities for laboratory automation, bioinformatics tools, and custom sequencing services.